世界のバイオ医薬品分析試験サービス市場は、予測期間中に約12.61 %のCAGRで加速し、2022年から2027年の間に34億4,957万USドルの成長が見込まれています。本レポートは、総体的な分析、市場規模と予測、動向、成長推進要因、課題、および約25社のベンダーを対象とするベンダー分析を提供しています。
本レポートは、現在の世界市場シナリオ、最新動向と成長推進要因、および全体的な市場環境に関する最新の分析を提供します。市場は、モノクローナル抗体(mAb)の需要の増加、特許期限切れの医薬品の増加、および慢性疾患の増加によって牽引されています。
本調査では、研究開発への投資の増加が、今後数年間のバイオ医薬品分析試験サービス市場の成長を促進する主要な理由の1つであると特定しています。また、ワクチンの生産量の増加や分析試験サービスのアウトソーシングの増加も、市場の大きな需要につながるでしょう。
TechNavio社の堅牢なベンダー分析は、クライアントが市場での地位を向上させるのに役立つように設計されており、これに沿って、主要なバイオ医薬品分析試験サービス市場ベンダーの詳細な分析を提供します
この調査は、業界の主要な参加者からの情報を含む、一次情報と二次情報の客観的な組み合わせを使用して実施されました。本レポートには、主要ベンダーの分析に加えて、包括的な市場とベンダー情勢が含まれています。
TechNavio社は、利益、価格設定、競争、プロモーションなどの主要なパラメーターの分析により、複数のソースからのデータの調査、統合、および集計により、市場の詳細な状況を提示します。また、業界の主要なインフルエンサーを特定することにより、さまざまな市場の側面を提示します。提示されたデータは、包括的で信頼性が高く、一次および二次の広範な調査の結果です。TechNavio社の市場調査レポートは、完全な競争環境と、質的および量的調査を使用して正確な市場成長を予測する詳細なベンダー選択の調査手法と分析を提供します。
目次
Table of Contents
1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Service
Exhibit 06: Executive Summary - Chart on Market Segmentation by End-user
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics
3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
4 Historic Market Size
4.1 Global biopharmaceutical analytical testing services market 2017 - 2021
Exhibit 18: Historic Market Size - Data Table on Global biopharmaceutical analytical testing services market 2017 - 2021 ($ million)
4.2 Service Segment Analysis 2017 - 2021
Exhibit 19: Historic Market Size - Service Segment 2017 - 2021 ($ million)
4.3 End-user Segment Analysis 2017 - 2021
Exhibit 20: Historic Market Size - End-user Segment 2017 - 2021 ($ million)
4.4 Geography Segment Analysis 2017 - 2021
Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
4.5 Country Segment Analysis 2017 - 2021
Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
6 Market Segmentation by Service
6.1 Market segments
Exhibit 30: Chart on Service - Market share 2022-2027 (%)
Exhibit 31: Data Table on Service - Market share 2022-2027 (%)
6.2 Comparison by Service
Exhibit 32: Chart on Comparison by Service
Exhibit 33: Data Table on Comparison by Service
6.3 Bioanalytical - Market size and forecast 2022-2027
Exhibit 34: Chart on Bioanalytical - Market size and forecast 2022-2027 ($ million)
Exhibit 35: Data Table on Bioanalytical - Market size and forecast 2022-2027 ($ million)
Exhibit 36: Chart on Bioanalytical - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on Bioanalytical - Year-over-year growth 2022-2027 (%)
6.4 Method development and validation - Market size and forecast 2022-2027
Exhibit 38: Chart on Method development and validation - Market size and forecast 2022-2027 ($ million)
Exhibit 39: Data Table on Method development and validation - Market size and forecast 2022-2027 ($ million)
Exhibit 40: Chart on Method development and validation - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on Method development and validation - Year-over-year growth 2022-2027 (%)
6.5 Stability testing - Market size and forecast 2022-2027
Exhibit 42: Chart on Stability testing - Market size and forecast 2022-2027 ($ million)
Exhibit 43: Data Table on Stability testing - Market size and forecast 2022-2027 ($ million)
Exhibit 44: Chart on Stability testing - Year-over-year growth 2022-2027 (%)
Exhibit 45: Data Table on Stability testing - Year-over-year growth 2022-2027 (%)
6.6 Others - Market size and forecast 2022-2027
Exhibit 46: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 47: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 48: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibit 49: Data Table on Others - Year-over-year growth 2022-2027 (%)
6.7 Market opportunity by Service
Exhibit 50: Market opportunity by Service ($ million)
7 Market Segmentation by End-user
7.1 Market segments
Exhibit 51: Chart on End-user - Market share 2022-2027 (%)
Exhibit 52: Data Table on End-user - Market share 2022-2027 (%)
7.2 Comparison by End-user
Exhibit 53: Chart on Comparison by End-user
Exhibit 54: Data Table on Comparison by End-user
7.3 Pharma and biotech companies - Market size and forecast 2022-2027
Exhibit 55: Chart on Pharma and biotech companies - Market size and forecast 2022-2027 ($ million)
Exhibit 56: Data Table on Pharma and biotech companies - Market size and forecast 2022-2027 ($ million)
Exhibit 57: Chart on Pharma and biotech companies - Year-over-year growth 2022-2027 (%)
Exhibit 58: Data Table on Pharma and biotech companies - Year-over-year growth 2022-2027 (%)
7.4 CROs - Market size and forecast 2022-2027
Exhibit 59: Chart on CROs - Market size and forecast 2022-2027 ($ million)
Exhibit 60: Data Table on CROs - Market size and forecast 2022-2027 ($ million)
Exhibit 61: Chart on CROs - Year-over-year growth 2022-2027 (%)
Exhibit 62: Data Table on CROs - Year-over-year growth 2022-2027 (%)
7.5 Market opportunity by End-user
Exhibit 63: Market opportunity by End-user ($ million)
8 Customer Landscape
8.1 Customer landscape overview
Exhibit 64: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 65: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibit 66: Data Table on Market share By Geographical Landscape 2022-2027 (%)
9.2 Geographic comparison
Exhibit 67: Chart on Geographic comparison
Exhibit 68: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2022-2027
Exhibit 69: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 70: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 71: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 72: Data Table on North America - Year-over-year growth 2022-2027 (%)
9.4 APAC - Market size and forecast 2022-2027
Exhibit 73: Chart on APAC - Market size and forecast 2022-2027 ($ million)
Exhibit 74: Data Table on APAC - Market size and forecast 2022-2027 ($ million)
Exhibit 75: Chart on APAC - Year-over-year growth 2022-2027 (%)
Exhibit 76: Data Table on APAC - Year-over-year growth 2022-2027 (%)
9.5 Europe - Market size and forecast 2022-2027
Exhibit 77: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 78: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 79: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 80: Data Table on Europe - Year-over-year growth 2022-2027 (%)
9.6 South America - Market size and forecast 2022-2027
Exhibit 81: Chart on South America - Market size and forecast 2022-2027 ($ million)
Exhibit 82: Data Table on South America - Market size and forecast 2022-2027 ($ million)
Exhibit 83: Chart on South America - Year-over-year growth 2022-2027 (%)
Exhibit 84: Data Table on South America - Year-over-year growth 2022-2027 (%)
9.7 Middle East and Africa - Market size and forecast 2022-2027
Exhibit 85: Chart on Middle East and Africa - Market size and forecast 2022-2027 ($ million)
Exhibit 86: Data Table on Middle East and Africa - Market size and forecast 2022-2027 ($ million)
Exhibit 87: Chart on Middle East and Africa - Year-over-year growth 2022-2027 (%)
Exhibit 88: Data Table on Middle East and Africa - Year-over-year growth 2022-2027 (%)
9.8 US - Market size and forecast 2022-2027
Exhibit 89: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibit 90: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibit 91: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 92: Data Table on US - Year-over-year growth 2022-2027 (%)
9.9 China - Market size and forecast 2022-2027
Exhibit 93: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibit 94: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibit 95: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibit 96: Data Table on China - Year-over-year growth 2022-2027 (%)
9.10 Japan - Market size and forecast 2022-2027
Exhibit 97: Chart on Japan - Market size and forecast 2022-2027 ($ million)
Exhibit 98: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
Exhibit 99: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibit 100: Data Table on Japan - Year-over-year growth 2022-2027 (%)
9.11 UK - Market size and forecast 2022-2027
Exhibit 101: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 102: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 103: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibit 104: Data Table on UK - Year-over-year growth 2022-2027 (%)
9.12 Germany - Market size and forecast 2022-2027
Exhibit 105: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 106: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 107: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 108: Data Table on Germany - Year-over-year growth 2022-2027 (%)
9.13 Market opportunity By Geographical Landscape
Exhibit 109: Market opportunity By Geographical Landscape ($ million)
10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 110: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends
11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 111: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 112: Overview on factors of disruption
11.4 Industry risks
Exhibit 113: Impact of key risks on business
12 Vendor Analysis
12.1 Vendors covered
Exhibit 114: Vendors covered
12.2 Market positioning of vendors
Exhibit 115: Matrix on vendor position and classification
12.3 Almac Group Ltd.
Exhibit 116: Almac Group Ltd. - Overview
Exhibit 117: Almac Group Ltd. - Product / Service
Exhibit 118: Almac Group Ltd. - Key offerings
12.4 Boston Analytical
Exhibit 119: Boston Analytical - Overview
Exhibit 120: Boston Analytical - Product / Service
Exhibit 121: Boston Analytical - Key news
Exhibit 122: Boston Analytical - Key offerings
12.5 Catalent Inc.
Exhibit 123: Catalent Inc. - Overview
Exhibit 124: Catalent Inc. - Business segments
Exhibit 125: Catalent Inc. - Key news
Exhibit 126: Catalent Inc. - Key offerings
Exhibit 127: Catalent Inc. - Segment focus
12.6 Charles River Laboratories International Inc.
Exhibit 128: Charles River Laboratories International Inc. - Overview
Exhibit 129: Charles River Laboratories International Inc. - Business segments
Exhibit 130: Charles River Laboratories International Inc. - Key news
Exhibit 131: Charles River Laboratories International Inc. - Key offerings
Exhibit 132: Charles River Laboratories International Inc. - Segment focus
12.7 Coriolis Pharma Research GmbH
Exhibit 133: Coriolis Pharma Research GmbH - Overview
Exhibit 134: Coriolis Pharma Research GmbH - Product / Service
Exhibit 135: Coriolis Pharma Research GmbH - Key offerings
12.8 Element Materials Technology Group Ltd.
Exhibit 136: Element Materials Technology Group Ltd. - Overview
Exhibit 137: Element Materials Technology Group Ltd. - Product / Service
Exhibit 138: Element Materials Technology Group Ltd. - Key offerings
12.9 Eurofins Scientific SE
Exhibit 139: Eurofins Scientific SE - Overview
Exhibit 140: Eurofins Scientific SE - Business segments
Exhibit 141: Eurofins Scientific SE - Key news
Exhibit 142: Eurofins Scientific SE - Key offerings
Exhibit 143: Eurofins Scientific SE - Segment focus
12.10 ICON plc
Exhibit 144: ICON plc - Overview
Exhibit 145: ICON plc - Product / Service
Exhibit 146: ICON plc - Key offerings
12.11 Intertek Group Plc
Exhibit 147: Intertek Group Plc - Overview
Exhibit 148: Intertek Group Plc - Business segments
Exhibit 149: Intertek Group Plc - Key news
Exhibit 150: Intertek Group Plc - Key offerings
Exhibit 151: Intertek Group Plc - Segment focus
12.12 Merck KGaA
Exhibit 152: Merck KGaA - Overview
Exhibit 153: Merck KGaA - Business segments
Exhibit 154: Merck KGaA - Key news
Exhibit 155: Merck KGaA - Key offerings
Exhibit 156: Merck KGaA - Segment focus
12.13 Pace Analytical Services LLC
Exhibit 157: Pace Analytical Services LLC - Overview
Exhibit 158: Pace Analytical Services LLC - Product / Service
Exhibit 159: Pace Analytical Services LLC - Key offerings
12.14 SGS SA
Exhibit 160: SGS SA - Overview
Exhibit 161: SGS SA - Business segments
Exhibit 162: SGS SA - Key offerings
Exhibit 163: SGS SA - Segment focus
12.15 Solvias AG
Exhibit 164: Solvias AG - Overview
Exhibit 165: Solvias AG - Product / Service
Exhibit 166: Solvias AG - Key news
Exhibit 167: Solvias AG - Key offerings
12.16 STERIS Plc
Exhibit 168: STERIS Plc - Overview
Exhibit 169: STERIS Plc - Business segments
Exhibit 170: STERIS Plc - Key news
Exhibit 171: STERIS Plc - Key offerings
Exhibit 172: STERIS Plc - Segment focus
12.17 West Pharmaceutical Services Inc.
Exhibit 173: West Pharmaceutical Services Inc. - Overview
Exhibit 174: West Pharmaceutical Services Inc. - Business segments
Exhibit 175: West Pharmaceutical Services Inc. - Key news
Exhibit 176: West Pharmaceutical Services Inc. - Key offerings
Exhibit 177: West Pharmaceutical Services Inc. - Segment focus
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 178: Inclusions checklist
Exhibit 179: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 180: Currency conversion rates for US$
13.4 Research methodology
Exhibit 181: Research methodology
Exhibit 182: Validation techniques employed for market sizing
Exhibit 183: Information sources
13.5 List of abbreviations
Exhibit 184: List of abbreviations
Stability and Storage
growth due to the increasing number of tests for infectious and chronic diseases: The incidence of infectious and chronic diseases has increased over the past decade. The outbreak of the COVID-19 pandemic in 2020 has increased the demand for laboratory testing for COVID-19 across the world. An increase in demand for laboratory testing for infectious diseases, such as COVID-19 and chronic diseases, will be a driver for the life sciences tools and services industry in the future. The growth of the tools and services industry will continue to be strong in emerging markets such as China and India. Developed economies such as Japan and the EU will exhibit moderate growth rates.
product development to decrease prices: As the pricing pressure increases, life sciences tools manufacturers will have to rethink product development processes. A value first product design philosophy can help control costs and deliver what customers value the most.
Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Service
Exhibits6: Executive Summary - Chart on Market Segmentation by End-user
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size - Data Table on Global biopharmaceutical analytical testing services market 2017 - 2021 ($ million)
Exhibits19: Historic Market Size - Service Segment 2017 - 2021 ($ million)
Exhibits20: Historic Market Size - End-user Segment 2017 - 2021 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibits23: Five forces analysis - Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition - Five forces 2022 and 2027
Exhibits30: Chart on Service - Market share 2022-2027 (%)
Exhibits31: Data Table on Service - Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Service
Exhibits33: Data Table on Comparison by Service
Exhibits34: Chart on Bioanalytical - Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Bioanalytical - Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Bioanalytical - Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Bioanalytical - Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Method development and validation - Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Method development and validation - Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Method development and validation - Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Method development and validation - Year-over-year growth 2022-2027 (%)
Exhibits42: Chart on Stability testing - Market size and forecast 2022-2027 ($ million)
Exhibits43: Data Table on Stability testing - Market size and forecast 2022-2027 ($ million)
Exhibits44: Chart on Stability testing - Year-over-year growth 2022-2027 (%)
Exhibits45: Data Table on Stability testing - Year-over-year growth 2022-2027 (%)
Exhibits46: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibits47: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibits48: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibits49: Data Table on Others - Year-over-year growth 2022-2027 (%)
Exhibits50: Market opportunity by Service ($ million)
Exhibits51: Chart on End-user - Market share 2022-2027 (%)
Exhibits52: Data Table on End-user - Market share 2022-2027 (%)
Exhibits53: Chart on Comparison by End-user
Exhibits54: Data Table on Comparison by End-user
Exhibits55: Chart on Pharma and biotech companies - Market size and forecast 2022-2027 ($ million)
Exhibits56: Data Table on Pharma and biotech companies - Market size and forecast 2022-2027 ($ million)
Exhibits57: Chart on Pharma and biotech companies - Year-over-year growth 2022-2027 (%)
Exhibits58: Data Table on Pharma and biotech companies - Year-over-year growth 2022-2027 (%)
Exhibits59: Chart on CROs - Market size and forecast 2022-2027 ($ million)
Exhibits60: Data Table on CROs - Market size and forecast 2022-2027 ($ million)
Exhibits61: Chart on CROs - Year-over-year growth 2022-2027 (%)
Exhibits62: Data Table on CROs - Year-over-year growth 2022-2027 (%)
Exhibits63: Market opportunity by End-user ($ million)
Exhibits64: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits65: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits66: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits67: Chart on Geographic comparison
Exhibits68: Data Table on Geographic comparison
Exhibits69: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits70: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits71: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits72: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits73: Chart on APAC - Market size and forecast 2022-2027 ($ million)
Exhibits74: Data Table on APAC - Market size and forecast 2022-2027 ($ million)
Exhibits75: Chart on APAC - Year-over-year growth 2022-2027 (%)
Exhibits76: Data Table on APAC - Year-over-year growth 2022-2027 (%)
Exhibits77: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits78: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits79: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits80: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits81: Chart on South America - Market size and forecast 2022-2027 ($ million)
Exhibits82: Data Table on South America - Market size and forecast 2022-2027 ($ million)
Exhibits83: Chart on South America - Year-over-year growth 2022-2027 (%)
Exhibits84: Data Table on South America - Year-over-year growth 2022-2027 (%)
Exhibits85: Chart on Middle East and Africa - Market size and forecast 2022-2027 ($ million)
Exhibits86: Data Table on Middle East and Africa - Market size and forecast 2022-2027 ($ million)
Exhibits87: Chart on Middle East and Africa - Year-over-year growth 2022-2027 (%)
Exhibits88: Data Table on Middle East and Africa - Year-over-year growth 2022-2027 (%)
Exhibits89: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits90: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits91: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits92: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits93: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibits94: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibits95: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits96: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits97: Chart on Japan - Market size and forecast 2022-2027 ($ million)
Exhibits98: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
Exhibits99: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibits100: Data Table on Japan - Year-over-year growth 2022-2027 (%)
Exhibits101: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibits102: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibits103: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits104: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits105: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits106: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits107: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits108: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits109: Market opportunity By Geographical Landscape ($ million)
Exhibits110: Impact of drivers and challenges in 2022 and 2027
Exhibits111: Overview on Criticality of inputs and Factors of differentiation
Exhibits112: Overview on factors of disruption
Exhibits113: Impact of key risks on business
Exhibits114: Vendors covered
Exhibits115: Matrix on vendor position and classification
Exhibits116: Almac Group Ltd. - Overview
Exhibits117: Almac Group Ltd. - Product / Service
Exhibits118: Almac Group Ltd. - Key offerings
Exhibits119: Boston Analytical - Overview
Exhibits120: Boston Analytical - Product / Service
Exhibits121: Boston Analytical - Key news
Exhibits122: Boston Analytical - Key offerings
Exhibits123: Catalent Inc. - Overview
Exhibits124: Catalent Inc. - Business segments
Exhibits125: Catalent Inc. - Key news
Exhibits126: Catalent Inc. - Key offerings
Exhibits127: Catalent Inc. - Segment focus
Exhibits128: Charles River Laboratories International Inc. - Overview
Exhibits129: Charles River Laboratories International Inc. - Business segments
Exhibits130: Charles River Laboratories International Inc. - Key news
Exhibits131: Charles River Laboratories International Inc. - Key offerings
Exhibits132: Charles River Laboratories International Inc. - Segment focus
Exhibits133: Coriolis Pharma Research GmbH - Overview
Exhibits134: Coriolis Pharma Research GmbH - Product / Service
Exhibits135: Coriolis Pharma Research GmbH - Key offerings
Exhibits136: Element Materials Technology Group Ltd. - Overview
Exhibits137: Element Materials Technology Group Ltd. - Product / Service
Exhibits138: Element Materials Technology Group Ltd. - Key offerings
Exhibits139: Eurofins Scientific SE - Overview
Exhibits140: Eurofins Scientific SE - Business segments
Exhibits141: Eurofins Scientific SE - Key news
Exhibits142: Eurofins Scientific SE - Key offerings
Exhibits143: Eurofins Scientific SE - Segment focus
Exhibits144: ICON plc - Overview
Exhibits145: ICON plc - Product / Service
Exhibits146: ICON plc - Key offerings
Exhibits147: Intertek Group Plc - Overview
Exhibits148: Intertek Group Plc - Business segments
Exhibits149: Intertek Group Plc - Key news
Exhibits150: Intertek Group Plc - Key offerings
Exhibits151: Intertek Group Plc - Segment focus
Exhibits152: Merck KGaA - Overview
Exhibits153: Merck KGaA - Business segments
Exhibits154: Merck KGaA - Key news
Exhibits155: Merck KGaA - Key offerings
Exhibits156: Merck KGaA - Segment focus
Exhibits157: Pace Analytical Services LLC - Overview
Exhibits158: Pace Analytical Services LLC - Product / Service
Exhibits159: Pace Analytical Services LLC - Key offerings
Exhibits160: SGS SA - Overview
Exhibits161: SGS SA - Business segments
Exhibits162: SGS SA - Key offerings
Exhibits163: SGS SA - Segment focus
Exhibits164: Solvias AG - Overview
Exhibits165: Solvias AG - Product / Service
Exhibits166: Solvias AG - Key news
Exhibits167: Solvias AG - Key offerings
Exhibits168: STERIS Plc - Overview
Exhibits169: STERIS Plc - Business segments
Exhibits170: STERIS Plc - Key news
Exhibits171: STERIS Plc - Key offerings
Exhibits172: STERIS Plc - Segment focus
Exhibits173: West Pharmaceutical Services Inc. - Overview
Exhibits174: West Pharmaceutical Services Inc. - Business segments
Exhibits175: West Pharmaceutical Services Inc. - Key news
Exhibits176: West Pharmaceutical Services Inc. - Key offerings
Exhibits177: West Pharmaceutical Services Inc. - Segment focus
Exhibits178: Inclusions checklist
Exhibits179: Exclusions checklist
Exhibits180: Currency conversion rates for US$
Exhibits181: Research methodology
Exhibits182: Validation techniques employed for market sizing
Exhibits183: Information sources
Exhibits184: List of abbreviations